Jonathan French, Sc.D.

Senior Science Advisor, Fellow II

Jonathan has over 10 years of drug development experience. He began his career as a project statistician; designing, analyzing and interpreting clinical trials in depression and ADHD. His primary areas of expertise range from model-based meta-analysis and applied Bayesian methods to modeling time-to-event data and missing data mechanisms.

Recent publications by this scientist

Pharmacometrics Golems: Exposure-Response Models in Oncology

March 15, 2022

Akash KhandelwalAna-Marija GrisicJonathan FrenchKarthik Venkatakrishnan. Clin Pharmacol Ther. Published online March 14, 2022. doi:10.1002/cpt.2564

View More

A model-based analysis to guide gonadotropin-releasing hormone receptor antagonist use for management of endometriosis

February 4, 2022

Pohl OBaron KRiggs MFrench JGarcia RGotteland JPBr J Clin Pharmacol20211– 13. doi:10.1111/bcp.15171

View More

Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab

January 22, 2022

Nadia TerranovaJonathan FrenchHaiqing DaiMatthew WiensAkash KhandelwalAna Ruiz-GarciaJuliane ManitzAnja von HeydebreckMary RuisiKevin ChinPascal GirardKarthik Venkatakrishnan. CPT Pharmacometrics Syst Pharmacol. 2022;11(3):333-347.

View More